Skip to main content
. 2020 Oct 14;105(12):1696–1704. doi: 10.1136/bjophthalmol-2020-317337

Figure 2.

Figure 2

Graphs showing change in visual acuity (VA) versus antivascular endothelial growth factor injections administered to all patient eyes with retinal vein occlusion in 6 months and 1 year. The 95% CIs are included. Mean VA change tended to increase with greater treatment intensity. BRVO, branch retinal vein occlusion; CRVO, central retinal vein occlusion.